Annex 22 EU AI Act – Impact on Software Validation and Data Integrity in Pharma
Annex 22 EU AI Act – Impact on Software Validation and Data Integrity in Pharma What is Annex 22 and why is it important? Annex 22, which forms part of the EU AI Act, effectively serves as the ‘new rulebook’ for Artificial Intelligence (AI) in pharmaceutical manufacturing regulation. This blog aims to align global regulators […]